Charité Research Organisation GmbH Campus-Virchow-Klinikum

Berlin 13353

0 studies enrolling now · 1 studies all time

What they study most

Non-Hodgkin's Lymphoma

Studies at this site

• A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants — Stopped early